[1]
Anjum, S. et al. 2024. Comparative effectiveness of cardiovascular, renal and safety outcomes of second-line antidiabetic drugs use in people with type 2 diabetes. History of Medicine. 10, 2 (Apr. 2024), 1270–1279. DOI:https://doi.org/10.17720/h7ycmf16.